BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3909359)

  • 1. Congenital dysfibrinogenemias. A review.
    Rocha E; Páramo JA; Aranda A; Cuesta B; Fernández J
    Ric Clin Lab; 1985; 15(3):205-29. PubMed ID: 3909359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary dysfibrinogenemia.
    Bithell TC
    Clin Chem; 1985 Apr; 31(4):509-16. PubMed ID: 3978780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysfibrinogenemia and thrombosis.
    Mosesson MW
    Semin Thromb Hemost; 1999; 25(3):311-9. PubMed ID: 10443961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital dysfibrinogenemia.
    Martinez J
    Curr Opin Hematol; 1997 Sep; 4(5):357-65. PubMed ID: 9288470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen Vicenza and Genova II: two new cases of congenital dysfibrinogenemia with isolated defect of fibrin monomer polymerization and inhibitory activity on normal coagulation.
    Rodeghiero F; Castaman GC; Dal Belin Peruffo A; Dini E; Galletti A; Barone E; Gastaldi G
    Thromb Haemost; 1987 Jun; 57(3):252-8. PubMed ID: 2958952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare inherited disorders of fibrinogen.
    Acharya SS; Dimichele DM
    Haemophilia; 2008 Nov; 14(6):1151-8. PubMed ID: 19141154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital dysfibrinogenemia.
    Rupp C; Beck EA
    Curr Probl Clin Biochem; 1984; 14():65-130. PubMed ID: 6150812
    [No Abstract]   [Full Text] [Related]  

  • 8. Criteria for the differentiation of dysfibrinogenemic states.
    Ratnoff OD; Forman WB
    Semin Hematol; 1976 Apr; 13(2):141-57. PubMed ID: 779032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inherited abnormalities of fibrinogen: 10-year clinical experience of an Italian group.
    Santacroce R; Cappucci F; Pisanelli D; Perricone F; Papa ML; Santoro R; Grandone E; Margaglione M
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):235-40. PubMed ID: 16651864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three abnormal fibrinogen variants with the same amino acid substitution (gamma 275 Arg----His): fibrinogens Bergamo II, Essen and Perugia.
    Reber P; Furlan M; Henschen A; Kaudewitz H; Barbui T; Hilgard P; Nenci GG; Berrettini M; Beck EA
    Thromb Haemost; 1986 Dec; 56(3):401-6. PubMed ID: 3563970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysfibrinogenemia in childhood: two cases of congenital dysfibrinogens.
    Kotlín R; Blažek B; Suttnar J; Malý M; Kvasnička J; Dyr JE
    Blood Coagul Fibrinolysis; 2010 Oct; 21(7):640-8. PubMed ID: 20829681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A three-dimensional consideration of variant human fibrinogens.
    Everse SJ; Spraggon G; Doolittle RF
    Thromb Haemost; 1998 Jul; 80(1):1-9. PubMed ID: 9684777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fibrinogenopathies.
    Morse EE
    Ann Clin Lab Sci; 1978; 8(3):234-8. PubMed ID: 350125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on antithrombin I (fibrin).
    Mosesson MW
    Thromb Haemost; 2007 Jul; 98(1):105-8. PubMed ID: 17597999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule.
    Niwa K; Mimuro J; Miyata M; Sugo T; Ohmori T; Madoiwa S; Tei C; Sakata Y
    Thromb Res; 2008; 121(6):773-80. PubMed ID: 17854865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ["Fibrinogen Kawaguchi": a hereditary dysfibrinogenemia characterized by defective release of fibrinopeptide A associated with altered polymerization of fibrin monomers].
    Saeki E; Matsuda M; Ichinose A; Samejima Y; Kasamatsu A; Ara R; Mitsuno K; Kihara T; Hara Y
    Nihon Ketsueki Gakkai Zasshi; 1985 Aug; 48(5):1229-35. PubMed ID: 4072586
    [No Abstract]   [Full Text] [Related]  

  • 17. Fibrinogen Marseille. A new case of congenital dysfibrinogenaemia.
    Soria J; Soria C; Juhan I; Perrimond H; Haverkate F; Orsini A
    Haemostasis; 1980; 9(4):214-25. PubMed ID: 7399353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of molecular structure and fibrin polymerization between two Bβ-chain N-terminal region fibrinogen variants, Bβp.G45C and Bβp.R74C.
    Kaido T; Yoda M; Kamijo T; Taira C; Higuchi Y; Okumura N
    Int J Hematol; 2020 Sep; 112(3):331-340. PubMed ID: 32562089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen Matsumoto I: a gamma 364 Asp-->His (GAT-->CAT) substitution associated with defective fibrin polymerization.
    Okumura N; Furihata K; Terasawa F; Nakagoshi R; Ueno I; Katsuyama T
    Thromb Haemost; 1996 Jun; 75(6):887-91. PubMed ID: 8822581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen.
    Haverkate F; Samama M
    Thromb Haemost; 1995 Jan; 73(1):151-61. PubMed ID: 7740487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.